Emerging Immunotherapeutics for Ovarian Cancer Symposium - The Antibody Society
![CLINICAL TRIALS [GANNET53]](http://www.gannet53.eu/_media/concept_of_eudario.png "CLINICAL TRIALS [GANNET53]")
CLINICAL TRIALS [GANNET53]
Current status and future prospects of PARP inhibitor clinical trials | CMAR
JCI Insight - Phase II clinical trial of metformin as a cancer stem cell–targeting agent in ovarian cancer
Tools in the pharmacologic arsenal for treatment of ovarian cancer.... | Download Scientific Diagram
An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor - Gynecologic
Rationale and study design of the CHIPPI-1808 trial: a phase III randomized clinical trial evaluating hyperthermic intraperitoneal chemotherapy (HIPEC) for stage III ovarian cancer patients treated with primary or interval cytoreductive surgery -
Upcoming Clinical Trials for Ovarian Cancer
Current treatment strategy in ovarian cancer is illustrated. HGSOC,... | Download Scientific Diagram
![Current ovarian cancer gene therapy clinical trials available in [114]... | Download Scientific Diagram](https://www.researchgate.net/publication/326137544/figure/tbl4/AS:667796010696706@1536226384048/Current-ovarian-cancer-gene-therapy-clinical-trials-available-in-114.png "Current ovarian cancer gene therapy clinical trials available in [114]... | Download Scientific Diagram")
Current ovarian cancer gene therapy clinical trials available in [114]... | Download Scientific Diagram
Ovarian Cancer | Patient Care
Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome - European Journal of Cancer
Clinical trials results for PARP Inhibitors in ovarian cancer. | Download Table
Ovarian cancer clinical trial workflow. Fig 1 depicts an overview on... | Download Scientific Diagram
Managing Ovarian Cancer in the Era of New Therapies
BEVACIZUMAB IN OVARIAN CANCER: Phase III Trial -Clinical Trials Ongoing | Download Table
Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial - The Lancet
Advances in ovarian cancer, from biology to treatment | Nature Cancer
Clinical Trial – Treatment for Ovarian Cancer.
Mucinous Ovarian Carcinoma | NEJM
Ovarian cancer treatment: late-stage pipeline partnerships
Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo- controlled, phase 2b trial - The Lancet Oncology
BEVACIZUMAB IN OVARIAN CANCER -Clinical Trials Ongoing | Download Table
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial - The Lancet
